Jean de Dieu Iragena

Datos Biográficos

ID9070841
NOMBREJean de Dieu Iragena
NOMBRESJean de Dieu
APELLIDOIragena
FIRMAIRAGENA J D
AFILIACIONESMakerere University
ORCID0000-0002-5237-9775
VERIFICADONo
TOTAL DE OBRAS2
TOTAL DE CITAS0
OBRAS COMO AUTOR2
OBRAS COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2023
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Tuberculosis laboratory capacity building in the WHO African Region

    Open AccessJean de Dieu Iragena, Achilles Katamba et al.ARTICLEPLOS Global Public Health2025

    Tuberculosis remains a leading infectious disease killer in the World Health Organization African Region, with 2.5 million cases and 404,000 deaths in 2023, including 112,000 people with HIV. There is slow progress with only 42% of the 75% targeted reduction in death by 2025. Out of 60,266 estimated multidrug-resistant TB cases in 2023, only 22,515 were notified. Laboratory diagnostic services in the African region still need urgent attention. By…

  • Effectiveness of Xpert MTB/RIF and the Line Probe Assay tests for the rapid detection of drug-resistant tuberculosis in the Central African Republic

    Open AccessAlain Farra, Karen Koula et al.ARTICLEPLOS Global Public Health2023

    The Xpert MTB/RIF and Line Probe Assay (LPA) tests are more and more frequently used in mycobacteria testing laboratories for the rapid diagnosis of multi-drug resistance (MDR-TB). In this study, we demonstrate the effectiveness of these tests in the Central African Republic. Rifampicin resistance cases detected by the Xpert MTB/RIF during the year 2020 are also underwent first- and second-line LPA, and a first-line of drug susceptibility testing…